Eukaryotic translation initiation factor 6 overexpression plays a major role in the translational control of gallbladder cancer.
Nicole Golob-SchwarzlChristina WodlejFlorian KleineggerMargit Gogg-KamererAnna Maria Birkl-ToeglhoferJohannes PetzoldAriane AigelsreiterMichael ThalhammerYoung Nyun ParkJohannes HaybaeckPublished in: Journal of cancer research and clinical oncology (2019)
Our data indicates that eIF6 overexpression plays a major role in the translational control of GBC, and indicates its potential as a new biomarker and therapeutic target in GBC.